Assessment of cognitive function in asymptomatic HIV-positive subjects

European Neurology

Volumn 42, Issue 4, 1999, Pages 225-229

  Grassi, Maria Pia ^a   Perin, Cecilia ^a   Borella, Monica ^a   Mangoni, Alfonso ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

CD4 count; Cognitive function; Disease stage; HIV; Neuropsychological assessment

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; COGNITION; CONTROLLED STUDY; DRUG ABUSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PSYCHOMETRY; RATING SCALE; RETROSPECTIVE STUDY; SCREENING TEST; STATISTICAL ANALYSIS;

EID: 0032699481     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000008112     Document Type: Article

References (22)

1. Schmitt FA, Wetherby MMC, Stern Y: Neuropsychological changes in human immunodeficiency virus infection; in Berger JR, Levy RM (eds): AIDS and the Nervous System. Philadelphia, Lippincott-Raven, 1997, pp 401-417.
2. McArthur JC, McClernon DR, Cronin MF, Nance-Sproson TE, Saah AJ, St Clair M, Lanier ER: Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann Neurol 1997;42:689-698.
3. Seines OA, Miller E, McArthur JC, Gordon B, Munoz A, Sheridan K, Fox R, Saah AJ and the Multicenter AIDS Cohort Study: HIV-1 infection: No evidence of cognitive decline during the asymptomatic stages. Neurology 1990;40: 204-208.
4. Stern Y, Liu X, Marder K, Todak G, Sano M, Ehrhardt A, Gorman J: Neuropsychological changes in a prospectively followed cohort of homosexual and bisexual men with and without HIV infection. Neurology 1995;45:467-472.
5. Poutiainen E, Elovaara I, Raininko R, Hokkanene L, Valle SL, Lahdevirta J, Livanainen M: Cognitive decline in patients symptomatic HIV-1 infection. No decline in asymptomatic infection. Acta Neurol Scand 1996;93:421-427.
6. Seines OA, Galai N, McArthur JC, Cohn S, Royal W III, Esposito D, Vlahov D: HIV infection and cognition in intravenous drug users: Long-term follow-up. Neurology 1997;48:223-230.
7. Centers for Disease Control and Prevention: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adult. MMWR 1992;41:1-4.
8. Center for Disease Control and Prevention: Classification system for human T-lymphotropic virus type III/lymphoadenopathy-associated virus infection. MMWR 1986;35:334-339.
9. Zung WWK: A Self-Rating Depression Scale. Arch General Psychiatry 1965;12:63-70.
10. Grassi MP, Clerici F, Perin C, Zocchetti C, Borella M, Cargnel A, Mangoni A: HIV infection and drug abuse: Influence on cognitive function. AIDS 1995;9:165-170.
11. Grassi MP, D'Arminio Monforte A, Perin C, Musicco M, Mangoni A, Aceti A, Alberici F, Bassetti D, Cargnel A, Carosi G, Chiodo F, Concia E, Filippini P, Gavazzeni G, Caggese L, Giannini V, Lingua A, Gritti F, Lazzarin A, Mazzotta F, Niero F, Minoli L, Pastore G, Visco G, Moroni M for the Italian ADC Screening Group: A modified version of Blessed Dementia Scale (MBDS): A useful tool for detecting HIV cognitive alterations. J Neurovirol 1996;2: 38.
12. Grassi MP, Perin C, Clerici F, Borella M, D'Arminio Monforte A, Zocchetti C, Moroni M, Mangoni A: HIV Dementia Assessment (HIV-DA): A rating scale for AIDS Dementia Complex Screening. Proc XI Int Conf on AIDS, Vancouver, July 7-12, 1996, p 295.
13. Grassi MP, D'Arminio Monforte A, Musicco M, Perin C, Moroni M and the Italian ADC Screening Group: Suitability of psychometric methods administered by infectious diseases clinicians to identify cognitive deficits in HIV-positive subjects. Proc Fifth EurConf on Clinical Aspects and Treatment of HIV Infection, Copenhagen, Sept 26-29, 1995, p 121.
14. Grassi MP, Perin C, Borella M, Clerici F, Zocchetti C, D'Arminio Monforte A, Vago L, Moroni M, Mangoni A: Study of the applicability of the scale HIV Dementia Assessment (HIVDA) in HIV seropositive subjects with and without cognitive deficits. Proc IX Research Project on AIDS (1996). Istituto Superiore di Sanità, Roma, Jan 13-17, 1997, p 319.
15. Grassi MP, Perin C, Clerici F, Zocchetti C, Borella M, Cargnel A, Mangoni A: Effects of HIV seropositivity and drug abuse on cognitive function. Eur Neurol 1997;37:48-52.
16. Becker JT, Sanchez J, Dew MA, Lopez OL, Dorst SK, Bank G: Neuropsychological abnormalities among HIV-infected individuals in a community-based sample. Neuropsychology 1997;11:592-601.
17. Boccellari AA, Dilley JW, Chambers DB, Yingling CD, Tauber MA, Moss AR, Osmond DH: Immune function and neuropsychological performance in HIV-1-infected homosexual men. J Acquir Immune Defic Syndr 1993;6:592-601.
18. Podraza AM, Bornestein RA, Whitacre CC, Para MF, Fass RJ, Rice RR, Nasrallah HA: Neuropsychological performance and CD4 levels in HIV-1 asymptomatic infection. J Clin Exp Neuropsychol 1994;16:777-783.
19. Janssen RS: Epidemiology and neuroepidemiology of human immunodeficiency virus infection; in Berger JR, Levy RM (eds): AIDS and the Nervous System. Philadelphia, Lippincott-Raven, 1997, pp 13-37.
20. Borstein RA, Nasrallah HA, Para MF, Pass RJ, Whitacre CC, Rice RRJ: Rate of CD4 decline and neuropsychological performance in HIV infection. Arch Neurol 1991;48:704-707.
21. Dal Pan GJ, Farzadegan H, Seines O, Hoover DR, Miller EN, Skolasky RL, Nance-Sproson TE, McArthur JC: Sustained cognitive decline in HIV infection: Relationship to CD4+ cell count, plasma viremia and p24 antigenemia. J Neurovirol 1998;4:95-99.
22. Concha M, Selnes OA, Vlahov D, Nance-Sproson T, Updike M, Royal W, Palenicek J, McArthur JC: Comparison of neuropsychological performance between AIDS-free injecting drug users and homosexual men. Neuroepidemiology 1997;16:78-85.